If you need more lookups,
subscriptions start at $34 USD/month.
Jeff Hatfield Location
United States
Jeff Hatfield Work
Board Member @ (August 2024 - Present)
Chairman of the Board @ (January 2023 - Present)
Chief Executive Officer @ (November 2020 - January 2023)
Board Member @ (December 2020 - Present)
Chairman of the Board @ (July 2022 - Present)
Member Of The Board Of Advisors @ (July 2019 - Present)
Adjunct Professor @ (October 2015 - Present)
Chairman of the Board @ (January 2017 - January 2021)
Chief Executive Officer @ (October 2017 - May 2020)
Board Member, Executive Committee Member @ (September 2011 - December 2016)
Chief Executive Officer @ (March 2004 - October 2016)
Board Director @ (June 2014 - December 2014)
SVP, Immunology and Virology Divisions @ (October 2000 - March 2004)
President and General Manager, Canada @ (January 1998 - October 2000)
Head of Market Access @ (May 1995 - January 1998)
Jeff Hatfield Education
The Wharton School
Master of Business Administration (M.B.A.)
1984-1985
Purdue University
Bachelor’s Degree (Pharmacy)
1976-1981
Jeff Hatfield Skills
Pharmaceutical Industry
Clinical Development
Product Launch
Biotechnology
Pharmaceutical Sales
Medical Affairs
Strategic Partnerships
Diabetes
Immunology
Start-ups
Lifesciences
Managed Care
Sales Effectiveness
Cross-functional Team Leadership
Executive Management
Life Sciences
Commercialization
Jeff Hatfield Summary
Jeff Hatfield, based in United States, is currently a Adjunct Professor at Purdue University. Jeff Hatfield brings experience from previous roles at Gate Bioscience, Vividion Therapeutics, Inc., Vividion Therapeutics. Inc. and Vir Biotechnology, Inc.. Jeff Hatfield holds a 1984 - 1985 Master of Business Administration (M.B.A.) @ The Wharton School. With a robust skill set that includes Pharmaceutical Industry, Clinical Development, Product Launch, Biotechnology, Pharmaceutical Sales and more. Jeff Hatfield has 2 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Jeff Hatfield?
Find contact details for 700 million professionals.